International journal of rheumatic diseases
Ivarmacitinib: A Novel Selective JAK1 Inhibitor for the Treatment of Rheumatoid Arthritis-Letter to the Editor.
Syeda Maliha, Hafsa Ali
Published: 202510.1111/1756-185x.70486
No abstract available for this study.